OBJECTIVE: @entity1144 is a prerequisite for the diagnosis of @entity209 ( @entity209 ). Precise measurement of visceral fat by bioelectrical impedance analysis (BIA) has been validated. The aim of this study was to investigate the diagnostic performance of BIA in @entity209 and validate the best cutoff in a large adult cohort. MATERIALS AND METHODS: The study was performed on the MELEN Study cohort-a prospectively designed survey on the prevalence of cardiometabolic risk factors in Turkish adults. The final cohort consisted of 2219 @entity1 . Weight and visceral body composition were measured without shoes in light indoor clothes using a bioimpedance analyzer (Omron BF 510; Omron Corp, Kyoto, Japan). Plasma concentrations of @entity165 , insulin, fasting @entity1674 , high-density lipoprotein @entity165 , @entity413 , and other biochemical variables were measured. The diagnostic performance of visceral fat measurement by BIA in @entity1 with @entity209 was assessed. RESULTS: @entity209 was detected in 751 @entity1 (520 @entity1 and 231 @entity1 with a mean age of 55 [12] years; 34% of the whole study population). Total body fat and visceral fat levels were higher in subjects with @entity209 . Correlation analyses showed that there were significant correlations between anthropometric and BIA measurements. Receiver operating curve characteristics of visceral adiposity revealed the best cutoff values as greater than 12% for @entity1 and greater than 9% for @entity1 . The diagnostic performance was good in both sexes (the sensitivity/specificity and area-under-the-curve values were 76%/75% and 0.83 for @entity1 and 83%/67% and 0.81 for @entity1 , respectively). CONCLUSIONS: Visceral fat measured with BIA is an easily applicable and useful method for identifying @entity1 with @entity209 . The best cutoff values were higher than 12% for @entity1 and higher than 9% for @entity1 .

Performance of bioelectrical impedance analysis in the diagnosis of XXXX .

@entity1 :: ('9606', 'Species') :: ['participants', 'women', 'patients', 'people', 'men'] @entity1674 :: ('MESH:D014280', 'Chemical') :: ['triglycerides'] @entity1144 :: ('MESH:D056128', 'Disease') :: ['Central obesity'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic syndrome', 'Metabolic syndrome', 'MetS'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol']
@entity209 :: (MESH:D008659,Disease) :: ['metabolic syndrome']
